跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL HEPATITIS B IMMUNOGLOBULIN VF (human) 400IU injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
CSL HEPATITIS B IMMUNOGLOBULIN VF (human) 400IU injection vial
Approved
STANDARD
CSL HEPATITIS B IMMUNOGLOBULIN VF (human) 400IU injection vial
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
1f9b2040c6cd7ab2
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
1f9b2040c6cd7ab2
Product Name
CSL HEPATITIS B IMMUNOGLOBULIN VF (human) 400IU injection vial
Artg Id
61214
Artg Name
CSL HEPATITIS B IMMUNOGLOBULIN VF (human) 400IU injection vial
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
1998-10-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f33052f765722103c79ccc822d56518d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9699d7da3c39672203e503d584649ded.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
1f9b2040c6cd7ab2
Type
Standard
Back to TGA Approvals